Loading...
Home
Track Kwality
Contact Us
FOR ORDERS
Ibm@kwalitypharma.com
+91 9779177677
FOR QUERY
info@kwalitypharma.com
+91 7657833389
FOR JOBS
hrd@kwalitypharma.com
+91 9888014228
Latest News
We are pleased to announce that Company has received the approval from the General Directorate of Medicines, Supplies and Drugs (DIGEMID), PERU for its Generic, Injectable & OSD (Unit -1 in Amritsar) and For Oncology, Injectable & OSD (Unit-3 in Himachal Pradesh)
Kwality develops it’s First Implant Injection : Goserelin Acetate Implant Injection
About
Facilities
Gallery
Investor Relations
Job Opportunities
Online Enquiry
Disclosure of other events or information
2019-20
Certificate under Reg 74(5) 30-09-2019 30-10-2020
Certificate under Reg 40(9) 30-09-2019 25-10-2020
Compliance Certificate under Reg 7(3) 30-09-2019 12-10-2019
Intimation of Trading Window Closure 01-10-2019
Intimation of AGM & Book Closure 06-09-2019
Outcome of Board Meeting 06-09-2019
Change in Name of Director 5-09-2019
Disclosure under Reg 29(1) of sebi sast11-08-2019
Appointment of Company Secretary 23-07-2019
Resignation of Company Secretary25-06-2019
Intimation of Trading Window Closure 31-03-2020
2020-21
CC under reg 7(3) 31-03-2020 06-05-2020
Certificate under reg 7(3) 31-03-2021 17-04-2021
Certificate Under Reg 40(9) 30-09-2020 22-10-2020
Certificate under Reg 40(9) 31-03-2021 16-04-2021
Certificate under reg 74(5) 30-09-2020 17-10-2020
certificate under reg 74(5) 31-03-2020 08-05-2020
certificate under reg 74(5) 31-03-2021 15-04-2021
certificate under reg 74(5) 31-12-2020 19-01-2021
Certificate under regulation 7(3) 30-09-2020 19-10-2020
Disclosure Non-Large Entity 31-03-2020 01-06-2020
Disclosure of Non- Large Corporate 31-03-2021 27-04-2021
Intimation of AGM and Book Closure 5-11-2020
Intimation of Re-appointment of Directors 16-01-2021
Intimation of Resignation of Internal Auditor 31-03-2021
Intimation of Trading Window Closure 01-10-2020
Intimation of Trading Window Closure 31-03-2021
Notice of AGM 05-11-2020
Outcome of AGM 30-11-2020
outcome of board Meeting 05-11-2020
Temporary Suspension of Operation due to Covid-19 22-04-2020
2021-22
CC under Reg 7(3) for year ended 31-03-22
Certificate under Reg 74(5) for qtr 31-03-22
Certificate under reg 74(5) for quarter ended 30-09-2021
CERTIFICATE UNDER REG 74(5) for quarter ended 31-12-2021
CERTIFICATE UNDER REG 74(5)for quarter ended 30-06-2021
Certificate under Regulation 40(9) for 31-03-22
Disclosure of Non-Large Entity on 31-03-22
Intimation for Appointment of Internal Auditor
Intimation of AGM and Book Closure
Intimation of Board Meeting 02-11-2021
Intimation of Board Meeting 12-10-2021
Intimation of Board Meeting 30-06-2021
Intimation of Trading Window Closure 30-09-2021
Intimation of Trading Window Closure 31-03-2022
Notice of postal Ballot to Shareholders
Outcome of AGM 30-09-2021
Outcome of Board Meeting 06-09-2021
Outcome of Board Meeting 10-11-2021
Reconcilation of Share Capital Audit Report for quarter ended 31-12-2021
Reconcilation of Share Capital AuditReport for quarter ended March 2022
Voting results and Scrutinizer Report for Migration to main Board
2022-23
Independent Director Appointment letter
Coorporate Governance Report for 31-03-2023
Intimation for Board Meeting for Financial Results 31-03-2023
Certificate under Regulation 7(3) for 31-03-2023
Certificate under Reg 40(9) for 31-03-2023
Certificate under Reg 74(5) for 31-03-2023
Disclosure of non-large corporate 31-03-2023
Appointment of Additional Director (Non-Executive and Non-Independent)
Certificate under Reg 74(5) for qtr ended 31-12-2022
Certificate under Regulation 74(5) for Qtr ended 30-06-2022
certificate under regulation 74(5) of (DP)Regulations, 2018
Compliance Certificate for quarter 30-09-2022
compliance certificate for quarter 31-12-2022
Corporate Governance Report 30-09-2022
Corporate Governance Report 30-06-2022
Corporate Governance Report 31-12-2022
Disclosure of Related Party Transaction for half year ended 30.09.2022
Disclosure of report under Regulation 10(7) of SEBI (SAST) Reg
Disclosure under Reg 30 Anvisa Approval
Disclosure under Reg 30 EU GMP Inspection
Disclosure under Regulation 30 HP and ASR plant Anvisa Approval
Intimation of AGM and Book Closure
Intimation of Appointment of ID
Intimation of resignation of Non- Executive Director
Intimation of Trading Window Closure 30-06-2022
Intimation of Trading Window Closure 30-09-2022
Intimation of Trading Window Closure 31-12-2022
Migration of Company from SME to Main Board of BSE Limited
Outcome of Board Meeting 06-09-2022
Submission of Notice of 39th AGM
Voting Results and Scrutinizer Report of 39th AGM
2023-24
Reconcilation of share capital audit report 31-03-2024
Shareholding Pattern 31-03-2024
Investor Grievance Report Report 31-03-2024
Corporate Governance Report 31-03-2024
Disclosure for non-large corporate for 31-03-2024
Reconcilation of Share Capital Report 31-12-2023
Reconcilation of share capital audit report 30-09-2023
Reconciliation of Share Capital Audit Report 30-06-2023
Resumption of operation
Intimation of Fire Accident
Certificate under Reg 7(3) of SEBI (LODR)
Corporate Governance Report 31-12-2023
corporate governance report 30-09-2023
Certificate under Reg 74(5) of SEBI (DP) Reg
Certificate under Reg 74(5) of DP(Regulation), 2018
Certificate under Regulation 74(5) for December qtr 2023
Investor Grievance Report 31-12-2023
Investor Grievance Report 30-09-2023
Investor Grievance Report 30-06-2023
Voting Result of Postal Ballot
Corporate Governance Report 30-06-2023
Certificate under Reg 74(5) for qtr ended 30-06-2023, 2018
Intimation of Board Meeting for Fiancial Results 30-06-2023
Intimation of Trading Window Closure 30-06-2023
Reconciliation of Share Capital Audit Report 30-06-2023
2024-25